PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 17, 2026Arthritis Care & Research2 citationsOpen Access

Real‐world Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

View Full Paper
JPJay J. PatelFMFauzia Hollangel MPHCPCaroline Packee

Key Points

  • This research aims to evaluate how monitoring hydroxychloroquine levels affects lupus outcomes in patients.
  • Conducted a prospective longitudinal cohort study.
  • Monitored hydroxychloroquine blood levels in patients with systemic lupus erythematosus.
  • Focused on patients with estimated glomerular filtration rate (eGFR) ≤75.
  • Improved control of systemic lupus erythematosus (SLE) was observed with blood level monitoring.
  • Patients with eGFR ≤75 benefited the most from hydroxychloroquine monitoring.

Abstract

HCQ blood level monitoring could improve SLE control, particularly in patients with eGFR ≤75, and enable optimal HCQ use.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Patel et al. (2026) studied this question.

synapsesocial.com/papers/69e1cfb15cdc762e9d8589e4https://doi.org/10.1002/acr.80059
Ask AI
Helpful
Bookmark
Share
View Full Paper